J T Lundquist, E E Büllesbach, P L Golden, T A Dix
Index: J. Pept. Res. 59(2) , 55-61, (2002)
Full Text: HTML
A series of neurotensin (NT)(8-13) analogs featuring substitution of the Arg8 and/or Arg9 residues with non-natural cationic amino acids was synthesized and evaluated for binding to the human NT receptor-1 (hNTR-1). The modifications were designed to probe specific steric and electrostatic requirements in the N-terminal cationic region of NT(8-13) for receptor binding as a general evaluation of the feasibility of incorporating minor structural changes into a peptide at a crucial polar receptor binding site. Many of the non-natural amino acids are more or less isosteric to Arg but more lipophilic as a result of addition of alkyl groups or through removal or replacement of NH character with methylene or methyl substituents, whereas others vary the distance between the cation and the alpha-amino acid carbon. Substitution of Arg8 with N(G)-alkylated Arg derivatives or homolysine (Hlys) maintained the subnanomolar affinity of NT(8-13) to the hNTR-1. Position 8 incorporation of Hlys produced the most favorable primary amine side-chain substitution to date. Moderate losses in affinity observed with position 9 substitutions were attributed to adverse steric effects. Doubly substituted [Hlys8, DAB9]NT(8-13), in which DAB is 2,4-diaminobutyric acid, was also prepared and tested as the shorter side-chain of DAB is known to be favored in position 9 of NT(8-13). This analog maintained 60% of NT(8-13) binding affinity making it the most favored des-guanidinium-containing analog known. These results demonstrate that adequate receptor binding affinity can be maintained over a structural range of Arg analogs, thus providing a range of peptides expected to exhibit altered pharmacokinetic properties. From the standpoint of the hNTR-1 cationic binding sites, these results help to map out the structural stringency inherent in the formation of a tight binding complex with NT(8-13) and related analogs.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Neurotensin (8-13) acetate salt
CAS:60482-95-3 |
C38H64N12O8 |
In vivo behavioral effects of stable, receptor-selective neu...
2005-03-01 [Neuropharmacology 48(3) , 417-25, (2005)] |
The neurotensin fragment AcNT(8-13) inhibits lowering of int...
2002-09-01 [Am. J. Physiol. Heart Circ. Physiol. 283(3) , H933-40, (2002)] |
Radiolabeling of multimeric neurotensin(8-13) analogs with t...
2007-07-01 [Appl. Radiat. Isot. 65(7) , 818-26, (2007)] |
Gq/11-induced and spontaneous waves of coordinated network a...
2005-02-16 [J. Neurosci. 25(7) , 1737-49, (2005)] |
Radionuclide imaging of small-cell lung cancer (SCLC) using ...
2006-05-01 [Nucl. Med. Biol. 33(4) , 505-12, (2006)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved